Display options
Share it on

Adv Hematol. 2014;2014:465623. doi: 10.1155/2014/465623. Epub 2014 Jan 15.

Plasma and red cell reference intervals of 5-methyltetrahydrofolate of healthy adults in whom biochemical functional deficiencies of folate and vitamin B 12 had been excluded.

Advances in hematology

Agata Sobczyńska-Malefora, Dominic J Harrington, Kieran Voong, Martin J Shearer

Affiliations

  1. The Nutristasis Unit, The Centre for Haemostasis and Thrombosis, GSTS Pathology (Part of King's Healthcare Partners), St. Thomas' Hospital, London SE1 7EH, UK.

PMID: 24527038 PMCID: PMC3914575 DOI: 10.1155/2014/465623

Abstract

5-Methyltetrahydrofolate (5-MTHF) is the predominant form of folate and a strong determinant of homocysteine concentrations. There is evidence that suboptimal 5-MTHF availability is a risk factor for cardiovascular disease independent of homocysteine. The analysis of folates remains challenging and is almost exclusively limited to the reporting of "total" folate rather than individual molecular forms. The purpose of this study was to establish the reference intervals of 5-MTHF in plasma and red cells of healthy adults who had been prescreened to exclude biochemical evidence of functional deficiency of folate and/or vitamin B12. Functional folate and vitamin B12 status was assessed by respective plasma measurements of homocysteine and methylmalonic acid in 144 healthy volunteers, aged 19-64 years. After the exclusion of 10 individuals, values for 134 subjects were used to establish the upper reference limits for homocysteine (13  μ mol/L females and 15  μ mol/L males) and methylmalonic acid (430 nmol/L). Subjects with values below these cutoffs were designated as folate and vitamin B12 replete and their plasma and red cell 5-MTHF reference intervals determined, N = 126: 6.6-39.9 nmol/L and 223-1041 nmol/L, respectively. The application of these intervals will assist in the evaluation of folate status and facilitate studies to evaluate the relationship of 5-MTHF to disease.

References

  1. J Chromatogr B Biomed Sci Appl. 2000 Jul 21;744(2):307-13 - PubMed
  2. Seizure. 2006 Mar;15(2):79-85 - PubMed
  3. Lancet. 2002 Mar 2;359(9308):747-52 - PubMed
  4. Metabolism. 1990 Sep;39(9):902-4 - PubMed
  5. Haematologica. 2006 Feb;91(2):231-4 - PubMed
  6. Circulation. 2006 Sep 12;114(11):1193-201 - PubMed
  7. Am J Clin Nutr. 1998 Feb;67(2):263-70 - PubMed
  8. Am J Clin Nutr. 1999 Mar;69(3):482-9 - PubMed
  9. Clin Chem. 1996 Apr;42(4):630-6 - PubMed
  10. J Clin Pathol. 1966 Jan;19(1):17-28 - PubMed
  11. Proc Nutr Soc. 2008 May;67(2):232-7 - PubMed
  12. Lancet. 2002 Sep 28;360(9338):1021-2; author reply 1022 - PubMed
  13. Am J Clin Nutr. 2011 Jul;94(1):359S-365S - PubMed
  14. Am J Clin Nutr. 2007 Nov;86(5):1563S-8S - PubMed
  15. Epilepsia. 1971 Jun;12(2):165-71 - PubMed
  16. Mol Genet Metab. 2006 Jan;87(1):61-5 - PubMed
  17. Haematologica. 2007 Apr;92(4):562-3 - PubMed
  18. Clin Chem. 1990 Feb;36(2):265-70 - PubMed
  19. Clin Chem. 2007 Apr;53(4):781-4 - PubMed
  20. Clin Lab Haematol. 2001 Feb;23(1):15-20 - PubMed
  21. Clin Chem. 2004 Feb;50(2):423-32 - PubMed
  22. Ann Clin Biochem. 2010 Nov;47(Pt 6):541-8 - PubMed
  23. Blood Coagul Fibrinolysis. 2009 Jun;20(4):297-302 - PubMed
  24. J Nutr Biochem. 2007 Oct;18(10):693-9 - PubMed
  25. Clin Chem. 2004 Dec;50(12):2378-81 - PubMed
  26. Vital Health Stat 11. 1998 Dec;(243):1-78 - PubMed
  27. Anal Biochem. 1994 Feb 1;216(2):424-6 - PubMed
  28. J Clin Chem Clin Biochem. 1987 May;25(5):337-42 - PubMed
  29. Food Nutr Bull. 2008 Jun;29(2 Suppl):S67-73 - PubMed
  30. Clin Chem. 1999 Feb;45(2):189-98 - PubMed
  31. Clin Chem. 2004 Jan;50(1):3-32 - PubMed
  32. Arterioscler Thromb Vasc Biol. 1996 Jun;16(6):727-33 - PubMed

Publication Types